Our previous whole-genome sequencing study further demonstrated that FRS2 copy number can increase by 3- to 25-fold in bladder cancer tissues, and this amplification correlates with elevated microvessel density and adverse prognosis [19]. The gene discussed is FRS2; the disease is urinary bladder cancer.